This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 16749350
Submitted by lobbyist on: July 15, 2013 08:52:20 AM
Accepted by Registrar on: July 15, 2013 12:00:00 AM
Lobbyist Information
| McCarthy, Michael |
| 65 Queen Street West Suite 2010 | |
|
Toronto, ON, M5H 2M5
|
416-362-6141 |
| Canada |
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbyist Firm Information
| Grosso McCarthy Inc. |
| 65 Queen Street West Suite 2010 | |
|
Toronto, ON, M5H 2M5
|
416-362-6141 |
| Canada |
Client Information
| Vertex Pharmaceuticals (Canada) Inc. |
| Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. |
| 275 Armad-Frappier Boulevard | |
|
Laval, QC, H7V 4A7
|
855-978-2216 |
| Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
| July 16, 2013 | |
| November 28, 2013 |
There are no other individuals engaged to lobby on this undertaking.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder
Development, establishment, amendment or termination of any program, policy or decision
Seeking to discuss Rare Disease Drug Access policy and the Pan-Canadian Value Price Initiative.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Lake, Terry | Minister of Health | July 15, 2013 |
| Public Agency | Health | July 15, 2013 |